Researchers at Karolinska Institute have potentially discovered a novel method to combat obesity and associated conditions by ...
Lilly’s newest obesity and diabetes medicines, widely known as GLP-1 drugs, are drawing rave reviews from doctors, researchers and patients for their ability to safely and effectively control blood ...
Eli Lilly and Novo are leading now, but there are multiple drug candidates waiting in the wings that could disrupt that duopoly in the future.
As the treatment of obesity in the 21st century takes a monumental turn, the need for quality care is more pressing than ever: Tips for starting a new obesity-focused practice.
Zepbound, a popular weight loss drug from Eli Lilly, may help people with sleep apnea. Based on recent findings, Eli Lilly ...
Sen. Bernie Sanders (I-Vt.), chair of the Senate Health, Education, Labor, and Pensions (HELP) Committee, launched an ...
A budget-busting 3.6 million Medicare recipients could now be eligible for coverage of the weight-loss drug Wegovy, a new KFF ...
(via Healthcare Triage) In mid to late 2023 there was a flurry of news reports about patients taking new weight loss drugs reporting associated mental health concerns, including suicidal thoughts.
(via Healthcare Triage) In mid to late 2023 there was a flurry of news reports about patients taking new weight loss drugs reporting associated mental health concerns, including suicidal thoughts.
According to its website, Lilly has two anti-obesity drugs in Phase 3 testing, orforglipron and retatrutide. Lilly has also partnered with Chinese drug developer Innovent Biologics on an anti ...
According to its website, Lilly has two anti-obesity drugs in Phase 3 testing, orforglipron and retatrutide. Lilly has also partnered with Chinese drug developer Innovent Biologics on an anti ...
They are the medications ... has a list price of $968.52 for a 28-day supply. Wegovy, a higher dose of the same medicine that's FDA-approved for weight loss in people with obesity or who are ...